Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Renovaro Biosciences ( (RENB) ) has provided an update.
On July 7, 2025, Renovaro Inc. restructured its debt by entering into an Exchange Agreement with existing accredited investors, converting $9.7 million in secured promissory notes into $16.1 million in new convertible promissory notes. These notes were immediately converted into 53.6 million shares of common stock, eliminating the secured debt and providing the company with greater financial flexibility. This transaction, which did not require stockholder approval under Nasdaq rules, is expected to support Renovaro’s strategic initiatives without involving any cash proceeds.
More about Renovaro Biosciences
Average Trading Volume: 3,560,936
Technical Sentiment Signal: Sell
Current Market Cap: $51.03M
For detailed information about RENB stock, go to TipRanks’ Stock Analysis page.